765
Views
41
CrossRef citations to date
0
Altmetric
Research Article

Co-occurring prescription opioid use problems and posttraumatic stress disorder symptom severity

, MS, , MA, , PhD, , PhD, , BA & , BA
Pages 304-311 | Received 04 Nov 2013, Accepted 23 Mar 2014, Published online: 08 May 2014

References

  • Joranson DE, Ryan KM, Gilson AM, Dahl JL. Trends in medical use and abuse of opioid analgesics. JAMA 2000;283:1710–1714
  • Miller NS. Prescription opiate medications: medical uses and consequences, laws and controls. Psychiatric Clin N Am 2004;27:689–708
  • Paulozzi LJ, Budnitz DS, Xi Y. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Safety 2006;15:618–627
  • Turk DC, Swanson KS, Gatchel RJ. Predicting opioid misuse by chronic pain patients: a systematic review and literature synthesis. Clinical J Pain 2008;24:497–508
  • McCauley JL, Danielson CK, Amstadter AB, Ruggiero KJ, Resnick HS, Hanson RF, Smith DW, et al. The role of traumatic event history in non-medical use of prescription drugs among a nationally representative sample of US adolescents. J Child Psychol Psychiatry 2010;51:84–93
  • Fleary SA, Heffer RW, McKyer EL. Dispositional, ecological and biological influences on adolescent tranquilizer, Ritalin, and narcotics misuse. J Adolescence 2011;34:653–663
  • Gonzales R, Brecht ML, Mooney L, Rawson RA. Prescription and over-the-counter drug treatment admissions to the California public treatment system. J Substance Abuse Treat 2011;40:224–229
  • Miller SC, Frankowski D. Prescription opioid use disorder: a complex clinical challenge. Curr Psychiatry 2012;11:14–21
  • Substance Abuse and Mental Health Services Administration (SAMHSA). Results from the 2009 National Survey on Drug Use and Health: Mental Health Findings; Rockville, MD, 2010
  • Compton WM, Volkow ND. Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend 2006;81:103–107
  • Manchikanti L. National drug control policy and prescription drug abuse: facts and fallacies. Pain Physician 2007;10:399–424
  • Hall AJ, Logan JE, Toblin RL, Kaplan JA, Kraner JC, Bixler D, Crosby AE, Paulozzi LJ. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA 2008;300:2613–2620
  • Okie S. A flood of opioids, a rising tide of deaths. New Eng J Med 2010;363:1981–1985
  • Birnbaum HG, White AG, Schiller M, Waldman T, Cleveland JM, Roland CL. Societal costs of prescription opioid abuse, dependence, and misuse in the United States. Pain Med 2011;12:657–667
  • Jones CM, Mack KA, Paulozzi LJ. Pharmaceutical overdose deaths, United States, 2010. JAMA 2013;309:657–659
  • Warner M, Chen LH, Makuc DM. Increase in fatal poisonings involving opioid analgesics in the United States, 1999–2006. NCHS Data Brief 2009;22:1–8
  • Warner M, Chen LH, Makuc DM, Anderson RN, Minino AM. Drug poisoning deaths in the United States, 1980–2008. NCHS Data Brief 2011;81:1–8
  • Moore BA, Fiellin DA, Barry DT, Sullivan LE, Chawarski MC, O’Connor PG, Schottenfeld RS. Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patients. J Gen Internal Med 2007;22:527–530
  • Rosenblum A, Parrino M, Schnoll SH, Fong C, Maxwell C, Cleland CM, Magura S, Haddox JD. Prescription opioid abuse among enrollees into methadone maintenance treatment. Drug Alcohol Depend 2007;90:64–71
  • McCauley JL, Amstadter AB, Danielson CK, Ruggiero KJ, Kilpatrick DG, Resnick HS. Mental health and rape history in relation to non-medical use of prescription drugs in a national sample of women. Addictive Behav 2009;34:641–648
  • Barry DT, Goulet JL, Kerns RK, Becker WC, Gordon AJ, Justice AC, Fiellin DA. Nonmedical use of prescription opioids and pain in veterans with and without HIV. Pain 2011;152:1133–1138
  • Tetrault JM, Desai RA, Becker WC, Fiellin DA, Concato J, Sullivan LE. Gender and non-medical use of prescription opioids: results from a national US survey. Addiction 2008;103:258–268
  • Becker WC, Sullivan LE, Tetrault JM, Desai RA, Fiellin DA. Non-medical use, abuse and dependence on prescription opioids among U.S. adults: psychiatric, medical and substance use correlates. Drug Alcohol Depend 2008;94:38–47
  • Back SE, Payne RL, Simpson AN, Brady KT. Gender and prescription opioids: findings from the National Survey on Drug Use and Health. Addictive Behav 2010;35:1001–1007
  • Parsells Kelly J, Cook SF, Kaufman DW, Anderson T, Rosenberg L, Mitchell AA. Prevalence and characteristics of opioid use in the US adult population. Pain 2008;138:507–513
  • McHugh RK, Devito EE, Dodd D, Carroll KM, Potter JS, Greenfield SF, Connery HS, Weiss RD. Gender differences in a clinical trial for prescription opioid dependence. J Substance Abuse Treat 2013;45:38–43
  • Huang B, Dawson DA, Stinson FS, Hasin DS, Ruan WJ, Saha TD, Smith SM, et al. Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: results of the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2006;67:1062–1073
  • Wu LT, Woody GE, Yang C, Blazer DG. How do prescription opioid users differ from users of heroin or other drugs in psychopathology: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Addiction Med 2011;5:28–35
  • Conway KP, Compton WM, Stinson FS, Grant BF. Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2006;67:247–257
  • Price AM, Ilgen MA, Bohnert AS. Prevalence and correlates of nonmedical use of prescription opioids in patients seen in a residential drug and alcohol treatment program. J Substance Abuse Treat 2011;41:208–214
  • Brooner RK, King VL, Kidorf M, Schmidt CW, Bigelow GE. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Arch Gen Psychiatry 1997;54:71–80
  • Weiss RD, Potter JS, Copersino ML, Prather K, Jacobs P, Provost S, Chim D, et al. Conducting clinical research with prescription opioid dependence: defining the population. Am J Addictions 2010;19:141–146
  • Weiss RD, Potter JS, Fiellin DA, Byrne M, Connery HS, Dickinson W, Gardin J, et al. Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial. Arch Gen Psychiatry 2011;68:1238–1246
  • Weiss RD, Potter JS, Provost SE, Huang Z, Jacobs P, Hasson A, Lindblad R, et al. A multi-site, two-phase, Prescription Opioid Addiction Treatment Study (POATS): rationale, design, and methodology. Contemp Clin Trials 2010;31:189–199
  • Brown PJ, Recupero PR, Stout R. PTSD substance abuse comorbidity and treatment utilization. Addictive Behav 1995;20:251–254
  • Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1995;52:1048–1060
  • Ouimette PC, Ahrens C, Moos RH, Finney JW. Posttraumatic stress disorder in substance abuse patients: relationship to 1-year posttreatment outcomes. Psychol Addictive Behav 1997;11:34–47
  • Ouimette PC, Brown PJ, Najavits LM. Course and treatment of patients with both substance use and posttraumatic stress disorders. Addictive Behav 1998;23:785–795
  • Ouimette PC, Read JP, Wade M, Tirone V. Modeling associations between posttraumatic stress symptoms and substance use. Addictive Behav 2010;35:64–67
  • Back SE, Dansky BS, Coffey SF, Saladin ME, Sonne S, Brady KT. Cocaine dependence with and without posttraumatic stress disorder: a comparison of substance use, trauma history and psychiatric comorbidity. Am J Addictions 2000;9:51–62
  • Cacciola JS, Alterman AI, McKay JR, Rutherford MJ. Psychiatric comorbidity in patients with substance use disorders: do not forget Axis II disorders. Psychiatric Annals 2001;31:321–331
  • Jacobsen LK, Southwick SM, Kosten TR. Substance use disorders in patients with posttraumatic stress disorder: a review of the literature. Am J Psychiatry 2001;158:1184–1190
  • Brady KT, Back SE, Coffey SF. Substance abuse and posttraumatic stress disorder. Curr Direct Psychological Sci 2004;13:206–209
  • Mills KL, Teesson M, Ross J, Darke S, Shanahan M. The costs and outcomes of treatment for opioid dependence associated with posttraumatic stress disorder. Psychiatric Services 2005;56:940–945
  • Reed PL, Anthony JC, Breslau N. Incidence of drug problems in young adults exposed to trauma and posttraumatic stress disorder: do early life experiences and predispositions matter? Arch Gen Psychiatry 2007;64:1435–1442
  • Sullivan TP, Holt LJ. PTSD symptom clusters are differentially related to substance use among community women exposed to intimate partner violence. J Traumatic Stress 2008;21:173–180
  • DiMaggio C, Galea S, Li G. Substance use and misuse in the aftermath of terrorism. A Bayesian meta-analysis. Addiction 2009;104:894–904
  • Seal KH, Cohen G, Waldrop AE, Cohen BE, Maguen S, Ren L. Substance use disorders in Iraq and Afghanistan veterans in VA healthcare, 2001–2010: implications for screening, diagnosis and treatment. Drug Alcohol Depend 2011;116:93–101
  • Dansky BS, Brady KT, Saladin ME, Killeen T, Becker S, Roitzsch J. Victimization and PTSD in individuals with substance use disorders: gender and racial differences. Am J Drug Alcohol Abuse 1996;22:75–93
  • Dore G, Mills K, Murray R, Teesson M, Farrugia P. Post-traumatic stress disorder, depression and suicidality in inpatients with substance use disorders. Drug Alcohol Review 2012;31:294–302
  • Mills KL, Lynskey M, Teesson M, Ross J, Darke S. Post-traumatic stress disorder among people with heroin dependence in the Australian treatment outcome study (ATOS): prevalence and correlates. Drug Alcohol Depend 2005;77:243–249
  • Mills KL, Teesson M, Ross J, Peters L. Trauma, PTSD, and substance use disorders: findings from the Australian National Survey of Mental Health and Well-Being. Am J Psychiatry 2006;163:652–658
  • Seal KH, Shi Y, Cohen G, Cohen BE, Maguen S, Krebs EE, Neylan TC. Association of mental health disorders with prescription opioids and high-risk opioid use in US veterans of Iraq and Afghanistan. JAMA 2012;307:940–947
  • Gros DF, Milanak ME, Brady KT, Back SE. Frequency and severity of comorbid mood and anxiety disorders in prescription opioid dependence. Am J Addictions 2013;22:261–255
  • Weathers FW, Litz BT, Huska JA, Keane TM. PTSD checklist – civilian version. Boston, MA: National Center for PTSD, Behavioral Science Division; 1994
  • Ruggiero KJ, Del Ben K, Scotti JR, Rabalais AE. Psychometric properties of the PTSD checklist-civilian version. J Traumatic Stress 2003;16:495–502
  • Blanchard EB, Jones-Alexander J, Buckley TC, Forneris CA. Psychometric properties of the PTSD checklist (PCL). Behav Res Ther 1996;34:669–673
  • Weathers FW, Litz BT, Herman DS, Huska JA, Keane TM. The PTSD checklist (PCL): Reliability, validity, and diagnostic utility. 9th Annual Meeting of the International Society for Traumatic Stress Studies; San Antonio, TX, 1993
  • Dobie DJ, Kivlahan DR, Maynard C, Bush KR, McFall M, Epler AJ, Bradley KA. Screening for post-traumatic stress disorder in female Veteran’s Affairs patients: validation of the PTSD checklist. Gen Hosp Psychiatry 2002;24:367–374
  • Forbes D, Creamer M, Biddle D. The validity of the PTSD checklist as a measure of symptomatic change in combat-related PTSD. Behav Res Therapy 2001;39:977–986
  • Grubaugh AL, Elhai JD, Cusack KJ, Wells C, Frueh BC. Screening for PTSD in public-sector mental health settings: the diagnostic utility of the PTSD checklist. Depression Anxiety 2007;24:124–129
  • Lang AJ, Laffaye C, Satz LE, Dresselhaus TR, Stein MB. Sensitivity and specificity of the PTSD checklist in detecting PTSD in female veterans in primary care. J Traumat Stress 2003;16:257–264
  • McDonald SD, Calhoun PS. The diagnostic accuracy of the PTSD checklist: a critical review. Clin Psychol Rev 2010;30:976–987
  • Mueser KT, Salyers MP, Rosenberg SD, Ford JD, Fox L, Carty P. Psychometric evaluation of trauma and posttraumatic stress disorder assessments in persons with severe mental illness. Psycholog Assess 2001;13:110–117
  • Stein MB, McQuaid JR, Pedrelli P, Lenox R, McCahill ME. Posttraumatic stress disorder in the primary care medical setting. Gen Hosp Psychiatry 2000;22:261–269
  • Terhakopian A, Sinaii N, Engel CC, Schnurr PP, Hoge CW. Estimating population prevalence of posttraumatic stress disorder: an example using the PTSD checklist. J Traumat Stress 2008;21:290–300
  • Ventureyra VA, Yao SN, Cottraux J, Note I, De Mey-Guillard C. The validation of the Posttraumatic Stress Disorder Checklist Scale in posttraumatic stress disorder and nonclinical subjects. Psychother Psychosomat 2002;71:47–53
  • Walker EA, Newman E, Dobie DJ, Ciechanowski P, Katon W. Validation of the PTSD checklist in an HMO sample of women. Gen Hosp Psychiatry 2002;24:375–380
  • Wilkins KC, Lang AJ, Norman SB. Synthesis of the psychometric properties of the PTSD checklist (PCL) military, civilian, and specific versions. Depression Anxiety 2011;28:596–606
  • Yeager DE, Magruder KM, Knapp RG, Nicholas JS, Frueh BC. Performance characteristics of the posttraumatic stress disorder checklist and SPAN in Veterans Affairs primary care settings. Gen Hosp Psychiatry 2007;29:294–301
  • McLellan AT, Luborsky L, Cacciola J, Griffith J, Evans F, Barr HL, O’Brien CP. New data from the Addiction Severity Index: reliability and validity in three centers. J Nervous Mental Dis 1985;173:412–423
  • Rikoon SH, Cacciola JS, Carise D, Alterman AI, McLellan AT. Predicting DSM-IV dependence diagnoses from Addiction Severity Index composite scores. J Substance Abuse Treat 2006;31:17–24
  • Bland JM, Altman DG. Multiple significance tests: the Bonferroni method. Br J Med 1995;310:170
  • Gelman A, Hill J, Yajima M. Why we (usually) don’t have to worry about multiple comparisons. J Res Educ 2012;5:189--211
  • Perneger TV. What’s wrong with Bonferroni adjustments? BMJ 1998;316:1236–1238
  • IBM Corporation. IBM SPSS Statistics for Windows, Version 21.0. Armonk, NY: IBM Corporation; 2012
  • Green TC, Grimes Serrano JM, Licari A, Budman SH, Butler SF. Women who abuse prescription opioids: findings from the Addiction Severity Index-Multimedia Version Connect prescription opioid database. Drug Alcohol Depend 2009;103:65–73
  • Norris FH, Foster JD, Weisshaar DL. The epidemiology of sex differences in PTSD across developmental, societal, and research contexts. In: Kimerling R, Ouimette PC, Wolfe J, eds. Gender and PTSD. New York, NY: The Guilford Press, 2002:3–42
  • Tolin DF, Foa EB. Sex differences in trauma and posttraumatic stress disorder: a quantitative review of 25 years of research. Psycholog Bull 2006;132:959–992
  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed. Arlington, VA: American Psychiatric Publishing; 2013
  • Hartwell KJ, Back SE, McRae-Clark AL, Shaftman SR, Brady KT. Motives for using: a comparison of prescription opioid, marijuana and cocaine dependent individuals. Addictive Behav 2012;37:373–378
  • Khantzian EJ. The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am J Psychiatry 1985;142:1259–1264
  • Brown PJ, Stout RL, Mueller TI. Substance use disorder and posttraumatic stress disorder comorbidity: addiction and psychiatric treatment rates. Psychol Addictive Behav 1999;13:115–122
  • Hien DA, Jiang H, Campbell AN, Hu MC, Miele GM, Cohen LR, Brigham GS, et al. Do treatment improvements in PTSD severity affect substance use outcomes? A secondary analysis from a randomized clinical trial in NIDA’s Clinical Trials Network. Am J Psychiatry 2010;167:95–101
  • Fiellin DA, Pantalon MV, Chawarski MC, Moore BA, Sullivan LE, O’Connor PG, Schottenfeld RS. Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence. New Eng J Med 2006;355:365–374
  • Fiellin DA, Barry DT, Sullivan LE, Cutter CJ, Moore BA, O’Connor PG, Schottenfeld RS. A randomized trial of cognitive behavioral therapy in primary care-based buprenorphine. Am J Med 2013;126:74.e11–77
  • Schwartz AC, Bradley R, Penza KM, Sexton M, Jay D, Haggard PJ, Garlow SJ, Ressler KJ. Pain medication use among patients with posttraumatic stress disorder. Psychosomatics 2006;47:136–142
  • Shipherd JC, Keyes M, Jovanovic T, Ready DJ, Baltzell D, Worley V, Gordon-Brown V, et al. Veterans seeking treatment for posttraumatic stress disorder: what about comorbid chronic pain? J Rehabil Res Develop 2007;44:153–166
  • Asmundson GJ, Katz J. Understanding pain and posttraumatic stress disorder comorbidity: do pathological responses to trauma alter the perception of pain? Pain 2008;138:247–249
  • Defrin R, Ginzburg K, Solomon Z, Polad E, Bloch M, Govezensky M, Schreiber S. Quantitative testing of pain perception in subjects with PTSD – implications for the mechanism of the coexistence between PTSD and chronic pain. Pain 2008;138:450–459
  • Sansone RA, Mueller M, Mercer A, Wiederman MW. Childhood trauma and pain medication prescription in adulthood. Int J Psychiatry Clin Pract 2010;14:248–251
  • Phifer J, Skelton K, Weiss T, Schwartz AC, Wingo A, Gillespie CF, Sands LA, et al. Pain symptomatology and pain medication use in civilian PTSD. Pain 2011;152:2233–2240

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.